Browsing INIBIC-EC-Artigos by Title
Now showing items 1-20 of 25
-
A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment
(Elsevier, 2023-12-15)[Abstract] Background: Thrombolytic recombinant tissue plasminogen activator (r-tPA) treatment is the only pharmacologic intervention available in the ischemic stroke acute phase. This treatment is associated with an ... -
Association of high serum levels of growth factors with good outcome in ischemic stroke: a multicenter study
(Springer Nature, 2019-11-25)[Abstract] The main objective of this research work was to study the association of serum levels of growth factors (GF) and SDF-1α with the functional outcome and reduction of lesion volume in ischemic stroke patients. In ... -
Characteristics of stroke units and stroke teams in Spain in 2018: Pre2Ictus project
(Elsevier, 2022-06-30)[Abstract] Introduction: The aim of this work is to describe the characteristics of stroke units and stroke teams in Spain. Method: We performed a cross-sectional study based on an ad hoc questionnaire designed by ... -
Comentario del CEIPV a las nuevas Guías Europeas de Prevención Cardiovascular 2021
(Elsevier en nombre de la Sociedad Española de Nefrología, 2022-06-10)[Resumen] Presentamos la adaptación española de las Guías Europeas de Prevención Cardiovascular 2021. En esta actualización además del abordaje individual, se pone mucho más énfasis en las políticas sanitarias como estrategia ... -
Depression in major neurodegenerative diseases and strokes: a critical review of similarities and differences among neurological disorders
(MDPI, 2023-02-13)[Abstract] Depression and anxiety are highly prevalent in most neurological disorders and can have a major impact on the patient’s disability and quality of life. However, mostly due to the heterogeneity of symptoms and ... -
Documento de consenso de la Sociedad Española de Ginecología y Obstetricia (SEGO) y el Comité Español Interdisciplinario para la Prevención Vascular (CEIPV): ventana de oportunidad: prevención del riesgo vascular en la mujer: resultados adversos del embarazo y riesgo de enfermedad vascular
(Sociedad Española de Ginecología y Obstetricia (SEGO), 2023)[Resumen] Este documento resume la evidencia que existe entre los resultados adversos del embarazo (RAE), tales como son los trastornos hipertensivos, el parto pretérmino, la diabetes gestacional, los defectos en el ... -
Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles: ¿qué parámetros debe incluir un perfil lipídico básico?
(Elsevier, 2023-03-14)[Resumen] Las enfermedades cardiovasculares (ECV) siguen siendo la principal causa de muerte en nuestro país. El control adecuado de las alteraciones del metabolismo lipídico es un reto clave en prevención cardiovascular ... -
Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology
(Elsevier, 2022-01)[Abstract] Objective: We present an update of the Spanish Society of Neurology's recommendations for prevention of both primary and secondary stroke in patients with dyslipidaemia. Development: We performed a ... -
Estudio de la situación actual del Teleictus en España
(Elsevier, 2023-08-07)[Resumen] Introducción. En los últimos años se ha establecido el uso del Teleictus como una herramienta fundamental para extender la atención a los pacientes con ictus agudo hasta hospitales que no disponen de neurólogos ... -
Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain
(Sage, 2020-06-11)[Abstract] Background and purpose: Spain has been one of the countries heavily stricken by COVID-19. But this epidemic has not affected all regions equally. We analyzed the impact of the COVID-19 pandemic on hospital ... -
Liquid chromatography fingerprint analysis of released compounds in plasmas samples of stroke patients after thrombolytic treatment
(MDPI, 2023-01-05)[Abstract] Plasma samples obtained from stroke patients treated with recombinant tissue-type plasminogen activator (rt-PA) and not treated with rt-PA were evaluated with different HPLC methodologies to obtain information ... -
Oral anticoagulation and risk of symptomatic hemorrhagic transformation in stroke patients treated with mechanical thrombectomy: data from the nordictus registry
(Frontiers, 2020-11-26)[Abstract] Introduction: We aimed to evaluate if prior oral anticoagulation (OAC) and its type determines a greater risk of symptomatic hemorrhagic transformation in patients with acute ischemic stroke (AIS) subjected to ... -
Prevención de ictus en pacientes con diabetes mellitus tipo 2 o prediabetes: recomendaciones del Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología
(Elsevier, 2020-09-24)[Resumen] Objetivo. Actualizar las recomendaciones de la Sociedad Española de Neurología para la prevención del ictus en pacientes con DM-2 o prediabetes, analizando las evidencias disponibles sobre el efecto del control ... -
Proprotein convertase subtilisin/kexin type 9 inhibitors in secondary prevention of vascular events in patients with stroke: consensus document and practice guidance
(Elsevier, 2021-12-11)[Abstract] Introduction: Patients with history of stroke or transient ischaemic attack present considerable risk of future vascular events. Reducing levels of low-density lipoprotein (LDL) cholesterol decreases the ... -
Recommendations of the Spanish Society of Neurology for the prevention of stroke: interventions on lifestyle and air pollution
(Elsevier, 2021-03-27)[Abstract] Objective: To update the recommendations of the Spanish Society of Neurology regarding lifestyle interventions for stroke prevention. Development: We reviewed the most recent studies related to lifestyle ... -
Retos principales a corto y medio plazo en el ictus
(Permanyer, 2022-05-28) -
RP11-362K2.2:RP11-767I20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma: a GWAS meta-analysis
(MDPI, 2021-07-16)[Abstract] Stroke is one of the most common causes of death and disability. Reperfusion therapies are the only treatment available during the acute phase of stroke. Due to recent clinical trials, these therapies may increase ... -
Síndrome de trombosis con trombocitopenia asociado a vacunas de adenovirus frente a la COVID-19: epidemiología y presentación clínica de la serie española
(Elsevier, 2022-05-23)[Resumen] Introducción. Se describen las características epidemiológicas y clínicas de los casos de síndrome de trombosis con trombocitopenia (STT) notificados en España. Métodos. Se incluyeron los casos de trombosis ... -
Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial)
(Springer Nature, 2024-01-09)[Abstract] Rationale: In-stent reocclusion after endovascular therapy has a negative impact on outcomes in acute ischemic stroke (AIS) due to tandem lesions (TL). Optimal antiplatelet therapy approach in these patients ... -
Stroke care during the COVID-19 outbreak in Spain: the experience of spanish stroke units
(BMJ, 2020-12-04)[Abstract] Background and purpose: Spain has been heavily affected by COVID-19. Reallocation of resources for managing the outbreak might have caused a disruption in stroke care. This study analyses the impact on stroke ...